CASE CONTROL STUDY OF LEVETIRACETAM VS. FOSPHENYTOIN FOR SEIZURE PROPHYLAXIS IN CHILDREN RECEIVING BUSULFAN (BU) FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

被引：0
|
作者：
Skeens, M. A.
Soni, S.
Pai, V
Bajwa, R.
Pietryga, D.
Gross, T.
Termuhlen, A.
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [21] Intravenous (IV) vs oral busulfan (BU) as part of a BU/CY (cyclophosphamide) preparative regimen for allogeneic hematopoietic stem cell transplantation (HSCT): Decreased incidence of hepatic veno-occlusive disease (VOD).
    Kashyap, A
    Wingard, J
    Cagnoni, P
    Tarantolo, S
    Fernandez, H
    Hu, W
    Gilfillan, K
    Faccuseh, M
    Niland, J
    Vaughan, W
    Jones, R
    Blume, K
    Champlin, R
    Forman, SJ
    Andersson, BS
    BLOOD, 1999, 94 (10) : 321B - 321B
  • [22] OUTCOME ANALYSIS IN PATIENTS RECEIVING PATERNAL VS. MATERNAL HEMATOPOIETIC STEM CELL TRANSPLANTATION.
    Kanangat, Siva
    Turner, Victoria
    Geiger, Terrance L.
    Yang, Jie
    Wong, Chong
    Leung, Wing
    HUMAN IMMUNOLOGY, 2010, 71 : S90 - S90
  • [23] Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation
    Schechter, Tal
    Finkelstein, Yaron
    Doyle, John
    Verjee, Zulfikarali
    Moretti, Myla
    Koren, Gideon
    Dupuis, L. Lee
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 307 - 314
  • [24] ORAL LORAZEPAM PREVENTS SEIZURE DURING HIGH-DOSE BUSULFAN IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A Prospective Study
    Hamidieh, Amir Ali
    Hamedani, Ravak
    Hadjibabaie, Molouk
    Amini, Mohsen
    Sadrai, Sima
    Ghavamzadeh, Ardeshir
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (07) : 529 - 533
  • [25] The importance of Therapeutic Drug Monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for Hematopoietic Stem Cell Transplantation (HSCT) in children
    Tesfaye, Hndie
    Branova, Romana
    Klapkova, Eva
    Prusa, Richard
    Janeckova, Daniela
    Riha, Petr
    Sedlacek, Petr
    Keslova, Petra
    Malis, Josef
    ANNALS OF TRANSPLANTATION, 2014, 19 : 214 - 224
  • [26] Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Aplastic Anemia: A Retrospective Study
    Si, Yingjian
    Luo, Rongmu
    Qin, Maoquan
    Du, Zhenlan
    Zhang, Xiaomei
    Wang, Ya
    Chen, Wei
    Gu, Wenjing
    Xing, Guosheng
    Dou, Lingsong
    Cao, Wei
    Feng, Zhichun
    ACTA HAEMATOLOGICA, 2023, 146 (06) : 466 - 473
  • [27] Busulfan for allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia: A retrospective study
    Si, Yingjian
    Luo, Rongmu
    Qin, Maoquan
    Du, Zhenlan
    Zhang, Xiaomei
    Wang, Ya
    Chen, Wei
    Gu, Wenjing
    Xing, Guosheng
    Dou, Lingsong
    Cao, Wei
    Feng, Zhichun
    ACTA HAEMATOLOGICA, 2023,
  • [28] Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation
    Charlotte Nykolyszyn
    Angela Granata
    Thomas Pagliardini
    Luca Castagna
    Samia Harbi
    Reda Bouabdallah
    Norbert Vey
    Sabine Fürst
    Valério Maisano
    Faezeh Legrand
    Claude Lemarié
    Boris Calmels
    Christian Chabannon
    Pierre-Jean Weiller
    Didier Blaise
    Raynier Devillier
    Bone Marrow Transplantation, 2020, 55 : 349 - 355
  • [29] Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation
    Nykolyszyn, Charlotte
    Granata, Angela
    Pagliardini, Thomas
    Castagna, Luca
    Harbi, Samia
    Bouabdallah, Reda
    Vey, Norbert
    Furst, Sabine
    Maisano, Valerio
    Legrand, Faezeh
    Lemarie, Claude
    Calmels, Boris
    Chabannon, Christian
    Weiller, Pierre-Jean
    Blaise, Didier
    Devillier, Raynier
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 349 - 355
  • [30] Decreased incidence of and risk factors for hepatic veno-occlusive disease with an intravenous busulfan (BU) containing preparative regimen for hematopoietic stem cell transplantation (HSCT).
    Vaughan, WP
    Cagnoni, P
    Fernandez, H
    Hu, W
    Kashyap, A
    Gian, V
    Wingard, J
    Tarantolo, S
    Andersson, BS
    BLOOD, 1998, 92 (10) : 516A - 516A
12345